BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30516454)

  • 1. Reducing Door-to-Needle Times for Ischaemic Stroke to a Median of 30 Minutes at a Community Hospital.
    Kamal N; Shand E; Swanson R; Hill MD; Jeerakathil T; Imoukhuede O; Heinrichs I; Bakker J; Stoyberg C; Fowler L; Duckett S; Holsworth S; Mann B; Valaire S; Bestard J
    Can J Neurol Sci; 2019 Jan; 46(1):51-56. PubMed ID: 30516454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
    Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
    JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving Door-to-Needle Times for Acute Ischemic Stroke: Effect of Rapid Patient Registration, Moving Directly to Computed Tomography, and Giving Alteplase at the Computed Tomography Scanner.
    Kamal N; Holodinsky JK; Stephenson C; Kashayp D; Demchuk AM; Hill MD; Vilneff RL; Bugbee E; Zerna C; Newcommon N; Lang E; Knox D; Smith EE
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time.
    Sauser K; Levine DA; Nickles AV; Reeves MJ
    JAMA Neurol; 2014 Sep; 71(9):1155-61. PubMed ID: 25023407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Decade of Improvement in Door-to-Needle Time Among Acute Ischemic Stroke Patients, 2008 to 2017.
    Tong X; Wiltz JL; George MG; Odom EC; Coleman King SM; Chang T; Yin X; ; Merritt RK
    Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004981. PubMed ID: 30557047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke.
    Xian Y; Xu H; Lytle B; Blevins J; Peterson ED; Hernandez AF; Smith EE; Saver JL; Messé SR; Paulsen M; Suter RE; Reeves MJ; Jauch EC; Schwamm LH; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of an emergency medicine pharmacist on door to needle alteplase time and patient outcomes in acute ischemic stroke.
    Barbour J; Hushen P; Newman GC; Vidal J
    Am J Emerg Med; 2022 Jan; 51():358-362. PubMed ID: 34823191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Bedside Preparation in Reducing "Door-to-Needle" Tissue-Type Plasminogen Activator (Alteplase) Administration Times and Association with Patient Outcomes.
    Lebahn KK; Waybright RA; Ngorsuraches S; Johnson TJ
    S D Med; 2018 Sep; 71(9):416-421. PubMed ID: 30308121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving door-to-needle times: a single center validation of the target stroke hypothesis.
    Ruff IM; Ali SF; Goldstein JN; Lev M; Copen WA; McIntyre J; Rost NS; Schwamm LH
    Stroke; 2014 Feb; 45(2):504-8. PubMed ID: 24399372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional Learning Collaboratives Produce Rapid and Sustainable Improvements in Stroke Thrombolysis Times.
    Prabhakaran S; Lee J; O'Neill K
    Circ Cardiovasc Qual Outcomes; 2016 Sep; 9(5):585-92. PubMed ID: 27625405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Telestroke Program Improves Thrombolysis for Acute Stroke Across 21 Hospitals of an Integrated Healthcare System.
    Nguyen-Huynh MN; Klingman JG; Avins AL; Rao VA; Eaton A; Bhopale S; Kim AC; Morehouse JW; Flint AC;
    Stroke; 2018 Jan; 49(1):133-139. PubMed ID: 29247142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in thrombolytic therapy administration in acute stroke with feedback.
    Ghrooda E; Alcock S; Jackson AC
    Can J Neurol Sci; 2012 Nov; 39(6):789-92. PubMed ID: 23041399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke.
    Xian Y; Smith EE; Zhao X; Peterson ED; Olson DM; Hernandez AF; Bhatt DL; Saver JL; Schwamm LH; Fonarow GC
    Stroke; 2014 May; 45(5):1387-95. PubMed ID: 24713527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with Low National Institutes of Health Stroke Scale Scores Have Longer Door-to-Needle Times: Analysis of a Telestroke Network.
    Bhatt A; Lesko A; Lucas L; Kansara A; Baraban E
    J Stroke Cerebrovasc Dis; 2016 Sep; 25(9):2253-8. PubMed ID: 27266620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal sustainability of guideline based door-to-needle times for intravenous thrombolysis for acute ischemic stroke.
    Raina A; Trivedi M; Kate M; Kumar L; Erat Sreedharan S; Sylaja PN
    J Clin Neurosci; 2020 Apr; 74():164-167. PubMed ID: 32094070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Door-to-Needle Delays in Minor Stroke: A Causal Inference Approach.
    Rostanski SK; Shahn Z; Elkind MSV; Liberman AL; Marshall RS; Stillman JI; Williams O; Willey JZ
    Stroke; 2017 Jul; 48(7):1980-1982. PubMed ID: 28536170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CODE FAST: a quality improvement initiative to reduce door-to-needle times.
    Busby L; Owada K; Dhungana S; Zimmermann S; Coppola V; Ruban R; Horn C; Rochestie D; Khaldi A; Hormes JT; Gupta R
    J Neurointerv Surg; 2016 Jul; 8(7):661-4. PubMed ID: 26089402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
    Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Local Tailoring on Acute Stroke Care in 21 Disparate Emergency Departments: A Prospective Stepped Wedge Type III Hybrid Effectiveness-Implementation Study.
    McKee KE; Knighton AJ; Veale K; Martinez J; McCann C; Anderson JW; Wolfe D; Blackburn R; McKasson M; Bardsley T; Ofori-Atta B; Greene TH; Hoesch R; Püttgen HA; Srivastava R
    Circ Cardiovasc Qual Outcomes; 2024 May; 17(5):e010477. PubMed ID: 38567507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phased changes in strategies can reduce delay of intravenous thrombolysis administration to 15 min.
    Itabashi R; Shigehatake Y; Yazawa Y; Endo K; Saito T; Fukuma K; Furui E; Mori E
    J Neurol Sci; 2019 Aug; 403():59-64. PubMed ID: 31226551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.